Molecular Diagnosis of Yeast Infections

P Lewis White1, Jessica S Price1, Alan Cordey1

  • 1Mycology Reference Laboratory, Public Health Wales, Microbiology Cardiff, UHW, Heath Park, Cardiff, CF14 4XW UK.

Abstract

Insights

Molecular diagnostics for invasive yeast infections show promise but face limited adoption due to standardization issues. Further validation and cost reduction are needed for broader clinical use, especially for emerging pathogens like Candida auris.

Area of Science:

  • Clinical Microbiology
  • Molecular Diagnostics
  • Mycology

Background:

  • Invasive yeast infections, particularly invasive candidosis, have relied on classical microbiology for diagnosis for over 20 years.
  • Molecular diagnostic tests for yeasts have been available for decades but face limited widespread clinical application.
  • Diagnosis remains heavily dependent on traditional culture-based methods, highlighting a need for improved diagnostic strategies.

Purpose of the Study:

  • To review developments in molecular diagnostics for yeast infections over the past decade.
  • To highlight the clinical performance, limitations, and novel approaches in yeast molecular diagnostics.
  • To address emerging challenges such as Candida auris and antifungal resistance.

Main Methods:

  • Review of recent literature on molecular diagnostic methods for yeast infections.
  • Evaluation of commercial molecular assays and their performance.
  • Analysis of technological advancements, including next-generation sequencing.

Main Results:

  • Limited methodological standardization and lack of commercial options have hindered molecular diagnostic integration.
  • Novel commercial methods show promise but require broader multicenter evaluation.
  • Molecular tests have improved the detection of emerging pathogens like Candida auris and understanding of antifungal resistance and epidemiology.

Conclusions:

  • Molecular methods for yeast infection diagnosis are limited to specialist centers, requiring further validation and cost reduction for broader use.
  • Standardization efforts, similar to Aspergillus PCR, are critical for yeast PCR adoption.
  • Next-generation sequencing offers potential for broad-range detection and insights into mycobiome and antifungal resistance.